Reuters logo
BRIEF-PharmaMar, Eczacıbaşı sign licensing agreement for Aplidin in Turkey
2017年5月25日 / 下午2点50分 / 6 个月前

BRIEF-PharmaMar, Eczacıbaşı sign licensing agreement for Aplidin in Turkey

May 25 (Reuters) - Pharma Mar Sa:

* Announced licensing agreement with Eczacibaşi Group to commercialize marine-derived anticancer drug Aplidin (Plitidepsin) in Turkey

* Under terms, co will receive an upfront payment as well as development milestones related to health approval procedure of Aplidin

* Co will retain exclusive production rights and will supply finished product to Eczacibaşi for commercial use Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below